SCHEMBL4641007

SCHEMBL4641007

CCc1cc(C(=O)OC(CC)CCC(C)C)c(C(=O)OC(CC)CCC(C)C)cc1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.43
PRKCD Q05655 2/20 0.43
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33
SCN3A Q9NY46 1/20 0.33
ADRA1A P35348 1/20 0.33
ALDH1A1 P00352 5/20 0.33
TP53 P04637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB1 P18505 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRB2 P47870 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641009 0.94 PRKCA (0.40) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640632 0.91 PRKCA (0.40) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640955 0.90 PRKCA (0.39) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640503 0.90 PRKCA (0.39) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4639861 0.87 PRKCA (0.43) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640589 0.87 PRKCA (0.56) PRKCAPRKCDADRA1AALDH1A1TP53
SCHEMBL4640664 0.86 PRKCA (0.36) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640634 0.86 PRKCA (0.36) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4642902 0.86 PRKCA (0.42) PRKCAPRKCDSCN1ASCN2ASCN3A
SCHEMBL4640960 0.85 PRKCA (0.36) PRKCAPRKCDALDH1A1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX PRKCA 1200/4885PRKCD 552/4885SCN1A 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.